Specialist Medical Review Council

Declaration

Section 196W
Veterans’ Entitlements Act 1986

Re: Statements of Principles Nos. 69 and 70 of 2012

in respect of Myeloma

Request for Review Declaration No. 23

1. In relation to the Repatriation Medical Authority (the RMA) Statement of Principles No. 70 of 2012 concerning myeloma and death from myeloma, made under subsection 196B (3) of the Veterans' Entitlements Act 1986 (the VEA), the Specialist Medical Review Council (the Council) under subsection 196W of the VEA:

DECLARES that the sound medical-scientific evidence available to the RMA is insufficient to justify an amendment to Statement of Principles No. 70 of 2012 to include a factor or factors in the same or similar terms to existing factors 6(c) and 6(d) in Statement of Principles No. 69 of 2012.

2.                  In relation to the RMA Statements of Principles Nos. 69 and 70 of 2012 concerning myeloma and death from myeloma, made under subsections 196B (2) and 196B (3) of the VEA, the Council under subsection 196W of the VEA:

DECLARES that there is sound medical-scientific evidence on which the RMA could have relied to amend both the Statements of Principles to include the factor set out below; and

DIRECTS the RMA to amend both Statements of Principles Nos. 69 and 70 of 2012 by including the following factor:

Having exposure to 2,3,7,8 tetrachlorodibenzo-para-dioxin (TCDD) sufficient to produce an expected initial serum TCDD level of at least 1500 parts per trillion before the clinical onset of myeloma.

The Common Seal of the )   
Specialist Medical Review )
Council was affixed to this )

document by authority of the )
Council in the presence of: )

Jan Bowman

       Registrar, SMRC

Dated this TWELFTH  day of   MAY  2014

The Council’s Reasons for Decisions in relation to this Declaration can be obtained from its website at www.smrc.gov.au, or on request by writing to The Registrar, PO Box 895, Woden ACT 2606 or by telephoning (07) 3223 8840.